RESUMO
Norovirus (NoV) is the main cause of gastroenteritis outbreaks worldwide. Although NoV spreads mainly from person to person, it is estimated that a large proportion of NoV outbreaks are caused by foodborne transmission. Bivalve mollusks are one of the most important foods involved in NoV transmission to humans. Little is known about NoV prevalence in shellfish harvested and commercialized in Brazil. The aim of this study was to map, for the first time, the distribution of NoV contamination in oysters and mussels harvested and commercialized in the coast of Pernambuco state, northeast Brazil. A total of 380 mollusks (260 oysters and 120 mussels) were collected between February and August 2017 either directly from harvesting areas or obtained from beach vendors at 17 sites in Pernambuco. Samples were processed and tested for NoV contamination using a SYBR Green real-time PCR assay. All samples were negative for NoV GI or GII contamination, suggesting a low risk of NoV contamination from this food source during the study period. Additional surveys in different areas of the Brazilian coast are warranted to monitor the risk of NoV infection upon seafood consumption.
Assuntos
Humanos , Animais , Norovirus/genética , Frutos do Mar , Brasil/epidemiologia , Contaminação de Alimentos/análise , Alimentos MarinhosRESUMO
The Infectious Bursal Disease Virus (IBDV) causes immunosuppression in young chickens. Advances in molecular virology and vaccines for IBDV have been achieved by viral reverse genetics (VRG). VRG for IBDV has undergone changes over time, however all strategies used to generate particles of IBDV involves multiple rounds of amplification and need of in vitro ligation and restriction sites. The aim of this research was to build the world's first VRG for IBDV by yeast-based homologous recombination; a more efficient, robust and simple process than cloning by in vitro ligation. The wild type IBDV (Wt-IBDV-Br) was isolated in Brazil and had its genome cloned in pJG-CMV-HDR vector by yeast-based homologous recombination. The clones were transfected into chicken embryo fibroblasts and the recovered virus (IC-IBDV-Br) showed genetic stability and similar phenotype to Wt-IBDV-Br, which were observed by nucleotide sequence, focus size/morphology and replication kinetics, respectively. Thus, IBDV reverse genetics by yeast-based homologous recombination provides tools to IBDV understanding and vaccines/viral vectors development.
Assuntos
Animais , Embrião de Galinha , Recombinação Homóloga , Vírus da Doença Infecciosa da Bursa/genética , Genética Reversa/métodos , Brasil , Células Cultivadas , Fibroblastos/virologia , Vetores Genéticos , Instabilidade Genômica , Vírus da Doença Infecciosa da Bursa/isolamento & purificação , Vírus da Doença Infecciosa da Bursa/fisiologia , Saccharomyces cerevisiae/genética , Transfecção , Cultura de Vírus , Replicação ViralRESUMO
Seqüenciamento e análise filogenética de 17 amostras do vírus da diarréia viral bovina (BVDV) isoladas no Brasil identificaram quatro amostras (23,5 por cento) do genótipo 1a (BVDV-1a), nove amostras (52,9 por cento) do genótipo 1b (BVDV tipo 1b) e quatro amostras (23,5 por cento) do genótipo 2 (BVDV tipo 2). As amostras brasileiras de BVDV tipo 2 apresentaram-se genotipicamente distintas dos BVDV tipo 2 até entäo identificados na América do Norte e Europa, sugerindo pertencerem a um novo subgenótipo. A caracterizaçäo antigênica dessas amostras por neutralizaçäo cruzada revelou reatividade sorológica muito reduzida com cepas vacinais do BVDV. O anti-soro produzido contra três cepas vacinais do BVDV apresentou atividade neutralizante muito reduzida contra várias amostras brasileiras de BVDV tipo 1 e 2. Diferenças de até 128 vezes nos títulos de anticorpos neutralizantes foram observadas entre cepas vacinais e amostras brasileiras do BVDV. Nos testes de soroneutralizaçäo (SN) contra o vírus dos tipos 1 e 2, de 1134 amostras testadas, 280 (24,7 por cento) possuiam anticorpos neutralizantes anti-BVDV e dessas, 215 (76,8 por cento) apresentaram atividade neutralizante contra ambos os vírus, 37 (13,2 por cento) reagiram apenas contra o BVDV tipo 2 e 28 amostras (10 por cento) foram positivas apenas contra o BVDV tipo 1. Esses resultados demonstram que testes de SN utilizando vírus de apenas um genótipo podem resultar em número significativo de falsos-negativos e indica a necessidade da formulaçäo de vacinas com amostras locais de BVDV e/ou contendo vírus dos dois genótipos